Updated:2024-10-24 04:07 Views:172
Experts express enthusiasm after US health regulators approved the first new form of treatment for schizophrenia in decades. INQUIRER FILES/STOCK IMAGE
Experts expressed enthusiasm after US health regulators approved the first new form of treatment for schizophrenia in decades.sulit777
The drug, called Cobenfy and developed by US pharma giant Bristol Myers Squibb, works differently from existing treatments, targeting the so-called cholinergic receptors, not the dopamine receptors.
“This drug takes the first new approach to schizophrenia treatment in decades,” Tiffany Farchione, a top official in the US Food and Drug Administration (FDA), said in a statement Thursday.
Article continues after this advertisement“This approval offers a new alternative to the antipsychotic medications people with schizophrenia have previously been prescribed,” she said.
FEATURED STORIES TECHNOLOGY vivo launches V40 Lite with 5000mAh battery covered by 50-month warranty, starts at Php 13,999 TECHNOLOGY Galaxy Buds3 Pro: Delivering tailored sound wherever you go TECHNOLOGY Very mindful, very intuitive: ASUS’ most superior AI PC yet, the Zenbook S 14, empowers you to achieve moreSchizophrenia affects only some one percent of Americans, but its effects can be devastating.
READ: Schizophrenia top mental disorder afflicting Filipinos who seek help, says study
Article continues after this advertisementIt can cause hallucinations, feelings of persecution, and difficulty in controlling one’s thoughts. About five percent of diagnosed schizophrenics die by suicide.
Article continues after this advertisementLynsey Bilsland, who heads the mental health division of the Wellcome charitable foundation, said Cobenfy could be “game-changing, especially for those for whom other drugs do not work.”
Article continues after this advertisementShe added: “It works in a completely different way from any other currently used schizophrenia drugs. It has the potential to change the lives of millions of people.”
Cobenfy – its scientific name is “xanomeline and trospium chloride” – is taken orally.
Article continues after this advertisementTwo clinical trials confirmed its effectiveness, showing it can significantly reduce patients’ symptoms.
Side effects include nausea, vomiting, indigestion, diarrhea, constipation, urinary retention, and liver problems.
READ: ‘Pig pen’ conditions at NCMH mirror state of PH mental health care
But compared to current drugs, those side effects are “reduced,” said Matt Jones, a professor of neuroscience at the University of Bristol in England.
“It’s obviously great news for people living with schizophrenia,” he said, while noting that the drug has yet to receive approval in Britain.
Sameer Jauhar, a senior clinical lecturer in affective disorders and psychosis at King’s College in London, said the side effects of current medications – including weight gain and sluggishness – can deter some people from following through with treatment.
Subscribe to our daily newsletter
He said he wants to see the results of longer-term trialssulit777, but quickly added that the positive results so far amount to “possibly one of the most exciting developments in our field, and I am very excited about this.”
TOPICS: drug, Medicine, mental health, schizophrenia READ NEXT Europe en route for moon with new simulator, says astronaut Pe... Ireland fines Meta 91 million euros over EU data breach EDITORS' PICK Espenido retracts drug-related allegations vs De Lima Central Visayas’ most wanted killed in shootout in Argao, Cebu Party-list system: What to know ahead of 2025 polls QC Mayor Belmonte highlights social services in State of City Address Kristine gets nearer; Metro Manila, 42 other areas under Signal No. 1 LIVE UPDATES: Tropical Storm Kristine MOST READ SC issues TRO vs Comelec resolution on dismissed public officials Tropical Storm Kristine slightly intensifies; Signal No. 2 in 5 areas Walang Pasok: Class suspensions on Wednesday, Oct. 23 LIVE UPDATES: Tropical Storm Kristine View comments